Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
TDP1 protein | 3 | 0 | 0 | 3 |
Smad3 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
arylsulfatase A | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
Histone H2A.x | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Bile salt export pump | 0 | 8 | 0 | 8 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
AR protein | 3 | 0 | 0 | 3 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
Beta-lactamase | 0 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 1 | 0 | 2 |
Beta-lactamase SHV-1 | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
Solute carrier family 15 member 1 | 0 | 3 | 0 | 4 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 2 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 2 | 6 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 2 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 2 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 2 | 6 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
GALC protein | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
IDH1 | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
geminin | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 1 | 5 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Beta-lactamase OXA-1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Class D beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 2 | 0 | 2 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
progesterone receptor | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 1 | 0 | 0 | 1 |
retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
G | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 2 | 4 |
Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 2 | 4 |
Kappa-type opioid receptor | 0 | 1 | 2 | 3 |
Mu-type opioid receptor | 0 | 2 | 1 | 4 |
Delta-type opioid receptor | 0 | 2 | 1 | 4 |
Kappa-type opioid receptor | 0 | 2 | 2 | 5 |
Mu-type opioid receptor | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 1 | 3 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1A adrenergic receptor | 0 | 4 | 2 | 6 |
Alpha-1B adrenergic receptor | 0 | 4 | 2 | 6 |
Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 1 | 3 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 1 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2C adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Valacyclovir hydrolase | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |